About the Authors

Rolf J. F. Ypma

rjfy2@cam.ac.uk

Affiliations Brain Mapping Unit, Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom, Hughes Hall, Cambridge, United Kingdom

Edward T. Bullmore

Affiliations Brain Mapping Unit, Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom, Behavioural and Clinical Neuroscience Institute, Department of Psychology, University of Cambridge, Cambridge, United Kingdom, Cambridgeshire & Peterborough NHS Foundation Trust, Cambridge, United Kingdom, ImmunoPsychiatry, Immuno-Inflammation Therapeutic Area Unit, GlaxoSmithKline, Stevenage, United Kingdom

Competing Interests

I have read the journal’s policy and the authors of this manuscript have the following competing interests: ETB is employed half-time by GlaxoSmithKline (GSK) and half-time by the University of Cambridge; he holds stock in GSK.

Author Contributions

Conceptualization: RJFY ETB. Formal analysis: RJFY. Funding acquisition: RJFY ETB. Methodology: RJFY. Resources: ETB. Software: RJFY. Supervision: ETB. Validation: RJFY. Visualization: RJFY. Writing original draft: RJFY. Writing review & editing: RJFY ETB.